Details of the Drug Formulations | DrugMAP

General Information of Drug (ID: DM5JVAN)

Drug Name

Fingolimod Drug Info

Synonyms

2-Amino-2-(4-octylphenethyl)propane-1,3-diol

Indication

Disease Entry	ICD 11	Status	REF
Multiple sclerosis	8A40	Approved	[1]
Primary progressive multiple sclerosis	8A40.1	Approved	[2]
Coronavirus Disease 2019 (COVID-19)	1D6Y	Phase 2	[3]

Cross-matching ID

PubChem CID: 107970
ChEBI ID: CHEBI:63115
CAS Number: 162359-55-9
TTD ID: D07UHS
INTEDE ID: DR0696
ACDINA ID: D00276

Full List of Drug Formulations Containing This Drug

Fingolimod 0.5 mg capsule

Company	Formulation ID	FDA Description
Novartis Pharmaceuticals Corporation	F08261	Magnesium stearate; Mannitol; Ferric oxide yellow; Titanium dioxide; Gelatin
------------------------------------------------------------------------------------

References

1	Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015
2	URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2407).
3	ClinicalTrials.gov (NCT04280588) Fingolimod in COVID-19